At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
Lamotrigine +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Different Antiepileptic Drug Monotherapies for the Occurrence of Premenstrual Dysphoric Disorder Among Women With Epilepsy
In Brief
An observational study evaluating Lamotrigine, Levetiracetam, and 2 other interventions for Epilepsy. Completed, enrolled 80 participants across 3 sites.
Detailed Summary
This study is being done to determine if there are differences in mood during the menstrual cycle among women with epilepsy who take various different antiepileptic drugs and women without epilepsy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEpilepsy
CountriesUnited States
CollaboratorsNewton-Wellesley Hospital, Brigham and Women's Hospital
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 2008
Enrollment StartApr 2008
Primary CompletionJun 2010
TodayJul 2026
First PostedFeb 11, 2008
Enrollment StartApr 1, 2008
Primary CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 18.4 years ago
Interventions
Lamotriginedrug
Subjects had at least 3 months on a stable dosage of lamotrigine monotherapy.
Levetiracetamdrug
Subjects had at least 3 months on a stable dosage of levetiracetam monotherapy.
Carbamazepinedrug
Subjects had at least 3 months on a stable dosage of carbamazepine monotherapy.
No Interventionother
No intervention was given